This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Matthew Nathan O'Brien Laramy
Introduction
Matthew Nathan O'Brien Laramy is an accomplished inventor based in Evanston, IL. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of COVID-19. His innovative work has garnered attention for its potential impact on public health.
Latest Patents
Laramy's most recent patent is titled "Compounds and methods for the treatment of COVID-19." This invention relates to specific compounds that can be used in pharmaceutical compositions to treat COVID-19. The patent outlines methods for administering therapeutically effective amounts of these compounds to inhibit or prevent the replication of SARS-CoV-2 in patients.
Career Highlights
Laramy is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of Laramy's notable coworkers include Robert Steven Kania and Padmavani Bezawada. Their collective expertise enhances the innovative environment at Pfizer, fostering advancements in medical treatments.
Conclusion
Matthew Nathan O'Brien Laramy exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the fight against COVID-19, highlight the importance of research and development in improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile